Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: A Wisconsin Oncology Network study

J. E. Chang, P. M. Voorhees, J. M. Kolesar, H. G. Ahuja, F. A. Sanchez, G. A. Rodriguez, K. Kim, J. Wemdli, H. H. Bailey, B. S. Kahl

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: A Wisconsin Oncology Network study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science